These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1549817)

  • 1. Seasonal onset of initial colonisation and chronic infection with Pseudomonas aeruginosa in patients with cystic fibrosis in Denmark.
    Johansen HK; Høiby N
    Thorax; 1992 Feb; 47(2):109-11. PubMed ID: 1549817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Pseudomonas aeruginosa lung infection in Danish cystic fibrosis patients.
    Pedersen SS; Jensen T; Høiby N; Koch C; Flensborg EW
    Acta Paediatr Scand; 1987 Nov; 76(6):955-61. PubMed ID: 3425313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Season is associated with Pseudomonas aeruginosa acquisition in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer J; Rosenfeld M
    Clin Microbiol Infect; 2013 Nov; 19(11):E483-9. PubMed ID: 23795938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral infections: a role in the lung disease of cystic fibrosis?
    Shale DJ
    Thorax; 1992 Feb; 47(2):69. PubMed ID: 1549825
    [No Abstract]   [Full Text] [Related]  

  • 5. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low incidence of pulmonary Pseudomonas cepacia infection in Danish cystic fibrosis patients.
    Nir M; Johansen HK; Høiby N
    Acta Paediatr; 1992 Dec; 81(12):1042-3. PubMed ID: 1283959
    [No Abstract]   [Full Text] [Related]  

  • 7. Controlled trial of cycled antibiotic prophylaxis to prevent initial Pseudomonas aeruginosa infection in children with cystic fibrosis.
    Tramper-Stranders GA; Wolfs TF; van Haren Noman S; van Aalderen WM; Nagelkerke AF; Nuijsink M; Kimpen JL; van der Ent CK
    Thorax; 2010 Oct; 65(10):915-20. PubMed ID: 20729233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimated risk of cross-infection with Pseudomonas aeruginosa in Danish cystic fibrosis patients.
    Høiby N; Pedersen SS
    Acta Paediatr Scand; 1989 May; 78(3):395-404. PubMed ID: 2787093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial sinusitis can be a focus for initial lung colonisation and chronic lung infection in patients with cystic fibrosis.
    Aanæs K
    J Cyst Fibros; 2013 Sep; 12 Suppl 2():S1-20. PubMed ID: 24064077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does centralized treatment of cystic fibrosis increase the risk of Pseudomonas aeruginosa infection?
    Pedersen SS; Jensen T; Pressler T; Høiby N; Rosendal K
    Acta Paediatr Scand; 1986 Sep; 75(5):840-5. PubMed ID: 3105236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide (LPS), LPS-immune complexes and cytokines as inducers of pulmonary inflammation in patients with cystic fibrosis and chronic Pseudomonas aeruginosa lung infection.
    Kronborg G
    APMIS Suppl; 1995; 50():1-30. PubMed ID: 7756034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients.
    Cantón R; Cobos N; de Gracia J; Baquero F; Honorato J; Gartner S; Alvarez A; Salcedo A; Oliver A; García-Quetglas E;
    Clin Microbiol Infect; 2005 Sep; 11(9):690-703. PubMed ID: 16104983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacteriology and treatment of infections in the upper and lower airways in patients with primary ciliary dyskinesia: adressing the paranasal sinuses.
    Alanin MC
    Dan Med J; 2017 May; 64(5):. PubMed ID: 28552099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibiotic therapy and effects of respiratory physiotherapy techniques in cystic fibrosis patients treated for acute lung exacerbations: an experimental study].
    da Silva Santos CI; Gonçalves de Oliveira Ribeiro MA; Moreno Morcillo A; Fernando Ribeiro A; Dirceu Ribeiro J
    Arch Bronconeumol; 2010 Jun; 46(6):310-6. PubMed ID: 20417019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
    Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
    Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction in prevalence of chronic Pseudomonas aeruginosa infection at a regional pediatric cystic fibrosis center.
    Lee TW; Brownlee KG; Denton M; Littlewood JM; Conway SP
    Pediatr Pulmonol; 2004 Feb; 37(2):104-10. PubMed ID: 14730654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pseudomonas aeruginosa infection in cystic fibrosis. The importance of early antibiotic therapy].
    Dutau G; Brémont F
    Rev Mal Respir; 1990; 7(3):183-5. PubMed ID: 2114027
    [No Abstract]   [Full Text] [Related]  

  • 18. Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients.
    Høiby N; Döring G; Schiøtz PO
    Antibiot Chemother (1971); 1987; 39():60-76. PubMed ID: 3118792
    [No Abstract]   [Full Text] [Related]  

  • 19. Eradication of early Pseudomonas aeruginosa infection.
    Høiby N; Frederiksen B; Pressler T
    J Cyst Fibros; 2005 Aug; 4 Suppl 2():49-54. PubMed ID: 16023416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seasonality of acquisition of respiratory bacterial pathogens in young children with cystic fibrosis.
    Psoter KJ; De Roos AJ; Wakefield J; Mayer JD; Rosenfeld M
    BMC Infect Dis; 2017 Jun; 17(1):411. PubMed ID: 28599639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.